Literature DB >> 2996528

Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.

D J Nathaniel, J F Evans, Y Leblanc, C Léveillé, B J Fitzsimmons, A W Ford-Hutchinson.   

Abstract

The epoxide 5(S) trans-5,6 oxido, 7,9 trans-11,14,17 cis eicosatetraenoic acid (leukotriene A5) was chemically synthesized and demonstrated to be both a substrate and an inhibitor of partially purified rat and human LTA4 hydrolase. Both rat and human LTA4 hydrolase utilized leukotriene A5 less effectively as a substrate than leukotriene A4. Incubation of leukotriene A5 (10 microM) or leukotriene A4 (10 microM) with rat neutrophils demonstrated formation of 123 pmol LTB5/min/10(7) cells and 408 pmol LTB4/min/10(7) cells respectively. Purified rat neutrophil LTA4 hydrolase incubated with 100 microM leukotriene A5 produced 22 nmol LTB5/min/mg protein and when incubated with 100 microM leukotriene A4 produced 50 nmol LTB4/min/mg protein. Human neutrophil LTA4 hydrolase incubated with 100 microM leukotriene A5 produced 24 nmol LTB5/min/mg protein and when incubated with 100 microM leukotriene A4 produced 52 nmol LTB4/min/mg protein. Leukotriene A5 was an inhibitor of the formation of leukotriene B4 from leukotriene A4 by both the rat and human neutrophil LTA4 hydrolase. Excess leukotriene A5 prevented covalent coupling of [3H] leukotriene A4 to LTA4 hydrolase suggesting inhibition may involve covalent coupling of leukotriene A5 to the LTA4 hydrolase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996528     DOI: 10.1016/0006-291x(85)91314-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis.

Authors:  J Z Haeggström
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Dietary fish oil blocks the microcirculatory manifestations of ischemia-reperfusion injury in striated muscle in hamsters.

Authors:  H A Lehr; C Hübner; D Nolte; A Kohlschütter; K Messmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  The comparative effects of dietary alpha-linolenic acid and fish oil on 4- and 5-series leukotriene formation in vivo.

Authors:  J Whelan; K S Broughton; J E Kinsella
Journal:  Lipids       Date:  1991-02       Impact factor: 1.880

4.  Properties of highly purified leukotriene C4 synthase of guinea pig lung.

Authors:  T Yoshimoto; R J Soberman; B Spur; K F Austen
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis.

Authors:  J B Lefkowith; G Schreiner
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 6.  Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs.

Authors:  Melissa Gabbs; Shan Leng; Jessay G Devassy; Md Monirujjaman; Harold M Aukema
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

7.  14,15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase.

Authors:  A Sala; M Garcia; S Zarini; J C Rossi; G Folco; T Durand
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

8.  Murine glomerular leukotriene B4 synthesis. Manipulation by (n-6) fatty acid deprivation and cellular origin.

Authors:  J B Lefkowith; A R Morrison; G F Schreiner
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

9.  Intravenous infusion of tridocosahexaenoyl-glycerol emulsion into rabbits. Effects on leukotriene B4/5 production and fatty acid composition of plasma and leukocytes.

Authors:  N Nakamura; T Hamazaki; K Yamazaki; H Taki; M Kobayashi; K Yazawa; F Ibuki
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.

Authors:  R I Sperling; A I Benincaso; C T Knoell; J K Larkin; K F Austen; D R Robinson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.